Arysta LifeScience Corporation today announced the immediate suspension of product sales for all formulations of the fumigant MIDASr in the United States.
"Arysta LifeScience remains committed to growers through our many other products," said Amy Yoder, Head of Arysta LifeScience North American Business Unit. "We will continue to develop and bring to market innovative solutions for growers in the crop protection market."
The company would like to express its gratitude to growers, researchers, business partners and supporters who helped MIDASr achieve U.S. EPA registration and registration in 48 states. LifeScience will continue to support the use of iodomethane outside of the U.S. where it remains economically viable.